Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence

被引:119
|
作者
Maurer, M. [1 ]
Metz, M. [1 ]
Bindslev-Jensen, C. [2 ,18 ]
Bousquet, J. [3 ,4 ,5 ]
Canonica, G. W. [6 ]
Church, M. K. [1 ]
Godse, K. V. [7 ]
Grattan, C. E. [8 ]
Hide, M. [9 ]
Kocaturk, E. [10 ]
Magerl, M. [1 ]
Makris, M. [11 ]
Meshkova, R. [12 ]
Saini, S. S. [13 ]
Sussman, G. [14 ]
Toubi, E. [15 ]
Zhao, Z. [16 ]
Zuberbier, T. [1 ]
Gimenez-Arnau, A. [17 ]
机构
[1] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, Charite Pl 1, D-10117 Berlin, Germany
[2] Odense Univ Hosp, Dept Dermatol, Odense Res Ctr Anaphylaxis, Odense, Denmark
[3] Univ Hosp, Montpellier, France
[4] INSERM, VIMA Ageing & Chron Dis, Epidemiol & Publ Hlth Approaches, Paris, France
[5] Univ Versailles St Quentin En Yvelines, UVSQ, UMR S 1168, St Quentin En Yvelines, France
[6] Univ Genoa, IRCCS AOU San Martino IST, Genoa, Italy
[7] DY Patil Sch Med, Dept Dermatol, Nerul, Navi Mumbai, India
[8] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[9] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dermatol, Hiroshima, Japan
[10] Okmeydani Training & Res Hosp, Dept Dermatol, Istanbul, Turkey
[11] Attikon Univ Hosp, Dept Dermatol & Venereol 2, Athens, Greece
[12] Smolensk State Med Univ, Dept Clin Immunol & Allergy, Smolensk, Russia
[13] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[14] Univ Toronto, Div Allergy & Immunol, Toronto, ON, Canada
[15] Technion Israel Inst Technol, Allergy & Clin Immunol, Bnai Zion Med Ctr, Haifa, Israel
[16] Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing, Peoples R China
[17] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, IMIM, Barcelona, Spain
[18] Odense Univ Hosp, Allergy Ctr, Odense Res Ctr Anaphylaxis, Odense, Denmark
关键词
angioedema; center; excellence; management; urticaria; QUALITY-OF-LIFE; VALIDATION; OMALIZUMAB; INSTRUMENT; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; NETWORK;
D O I
10.1111/all.12901
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BackgroundGA(2)LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. AimsHere, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA(2)LEN UCAREs. ResultsThe main aims of GA(2)LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA(2)LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and ConclusionThe GA(2)LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
引用
收藏
页码:1210 / 1218
页数:9
相关论文
共 50 条
  • [31] Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
    Bousquet, J.
    Bachert, C.
    Canonica, G. W.
    Mullol, J.
    Van Cauwenberge, P.
    Jensen, C. Bindslev
    Fokkens, W. J.
    Ring, J.
    Keith, P.
    Lorber, R.
    Zuberbier, T.
    ALLERGY, 2009, 64 (10) : 1516 - 1523
  • [32] Chronic rhinosinusitis in Europe - summary of epidemiological papers of the GA2LEN study
    Olze, H.
    Zuberbier, T.
    Bachert, C.
    ALLERGOLOGIE, 2012, 35 (03) : 110 - 114
  • [33] Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
    Hastan, D.
    Fokkens, W.
    Bachert, C.
    Tomassen, P.
    Newson, R.
    Jarvis, D.
    Bislimovska, J.
    Bockelbrink, A.
    Bousquet, P.
    Bousquet, J.
    Brozek, G.
    Bruno, A.
    Dahlen, S.
    Forsberg, B.
    Gunnbjoernsdottir, M.
    Kasper, L.
    Kraemer, U.
    Kowalski, M.
    Lange, B.
    Lundbaeck, B.
    Salagean, M.
    Todo-Bom, A.
    Toskala, E.
    Zuberbier, T.
    ALLERGY, 2011, 66 : 128 - 128
  • [34] Adaptation and initial results of the Polish version of the GA2LEN Chronic Urticaria Quality Of Life Questionnaire (CU-Q2oL)
    Brzoza, Z.
    Badura-Brzoza, K.
    Mlynek, A.
    Magerl, M.
    Baiardini, I.
    Canonica, G. W.
    Weller, K.
    Kocaturk, E.
    Kalogeromitros, D.
    Zalewska-Janowska, A.
    Zuberbier, T.
    Maurer, M.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 62 (01) : 36 - 41
  • [35] Chronic Rhinosinusitis Impairs Sleep Quality: Results of the GA2LEN Study
    Bengtsson, Caroline
    Lindberg, Eva
    Jonsson, Lars
    Holmstrom, Mats
    Sundbom, Fredrik
    Hedner, Jan
    Malinovschi, Andrei
    Middelveld, Roelinde
    Forsberg, Bertil
    Janson, Christer
    SLEEP, 2017, 40 (01)
  • [36] Snoring and environmental exposure: results from the Swedish GA2LEN study
    Silverforsen, Daniel
    Theorell-Haglow, Jenny
    Ljunggren, Mirjam
    Middelveld, Roelinde
    Wang, Juan
    Franklin, Karl
    Norback, Dan
    Lundback, Bo
    Forsberg, Bertil
    Lindberg, Eva
    Janson, Christer
    BMJ OPEN, 2021, 11 (06):
  • [37] Ragweed sensitization in Europe - GA2LEN study suggests increasing prevalence
    Burbach, G. J.
    Heinzerling, L. M.
    Roehnelt, C.
    Bergmann, K. -C.
    Behrendt, H.
    Zuberbier, T.
    ALLERGY, 2009, 64 (04) : 664 - 665
  • [38] Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
    Hastan, D.
    Fokkens, W. J.
    Bachert, C.
    Newson, R. B.
    Bislimovska, J.
    Bockelbrink, A.
    Bousquet, P. J.
    Brozek, G.
    Bruno, A.
    Dahlen, S. E.
    Forsberg, B.
    Gunnbjornsdottir, M.
    Kasper, L.
    Kraemer, U.
    Kowalski, M. L.
    Lange, B.
    Lundback, B.
    Salagean, E.
    Todo-Bom, A.
    Tomassen, P.
    Toskala, E.
    van Drunen, C. M.
    Bousquet, J.
    Zuberbier, T.
    Jarvis, D.
    Burney, P.
    ALLERGY, 2011, 66 (09) : 1216 - 1223
  • [39] Clinical impact in quality of life of EAACI/GA2LEN/EDF/WAO guidelines for chronic spontaneous urticaria: evaluation step by step
    Sanchez, J.
    Zakzuk, J.
    Cardona, R.
    ALLERGY, 2016, 71 : 39 - 39
  • [40] The high prevalence of chronic rhinosinusitis in Europe: findings from the ga2len questionnaire
    Fokkens, W.
    Kok, J.
    Bachert, C.
    ALLERGY, 2009, 64 : 597 - 598